col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Transplantation and Cellular Therapy
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―19 Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients Sandra Easdale, Robyn Shea, Lauren Ellis, Jessica Bazin, Kim Davis, Fiona Dallas, et al. (+6)
2 [GO] 2021―Jul―15 Safety and Tolerability of SARS-CoV-2 Emergency-Use Authorized Vaccines Allogeneic Hematopoietic Stem Cell Transplant Recipients. Haris Ali, Dat Ngo, Ahmed Aribi, Shukaib Arslan, Sanjeet Dadwal, Guido Marcucci, et al. (+4)
3 [GO] 2021―Jul―10 Impact of SARS-CoV-2 in hematopoietic stem cell transplant and CAR-T cell therapy recipients Muhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, Mary Luder, Nausheen Ahmed, Haitham Abdelhakim, et al. (+10)
4 [GO] 2021―Jun―30 Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy - a Single Center Prospective Cohort Study Ron Ram, David Hagin, Nino Kikozashvilli, Tal Freund, Odelia Amit, Yael Bar-On, et al. (+14)
5 [GO] 2021―May―25 Attitudes about Donating Stem Cells during COVID-19 among African American and Hispanic Members of an Unrelated Donor Registry Galen E. Switzer, Megan E. Hamm, Jessica G. Bruce, Alicia Dawdani, Vidya Kuniyil, Deborah Mattila, et al. (+5)
6 [GO] 2021―May―05 Cryopreservation of unrelated hematopoietic stem cells from a blood and marrow donor bank during the COVID-19 pandemic. A nationwide survey by the Japan Marrow Donor Program Yoshinobu Kanda, Masami Inoue, Naoyuki Uchida, Yasushi Onishi, Reiko Kamata, Mika Kotaki, et al. (+10)
7 [GO] 2021―Apr―23 COVID-19 and Hematopoietic Cell Transplant Center-specific survival analysis: Can we adjust for the impact of the pandemic? Recommendations of the COVID-19 Taskforce of the 2020 CIBMTR Center Outcomes Forum John R. Wingard, Kwang Woo Ahn, Christopher Dandoy, Miguel-Angel Perales, William A. Wood, Brent Logan, et al. (+2)
8 [GO] 2021―Mar―23 The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplant Outcomes: A CIBMTR Analysis. Implications During The COVID-19 Pandemic Jack W. Hsu, Nosha Farhadfar, Hemant Murthy, Brent R. Logan, Stephanie Bo-Subait, Noelle Frey, et al. (+10)
9 [GO] 2021―Mar―07 COVID-19 Cliff Notes-A COVID-19 Multi-disciplinary Care Compendium KM Williams, PT Wilson, F Silva-Palacios, J Kebbe, AD LaBeaud, Higuita N Agudelo, et al. (+6)
10 [GO] 2021―Feb―16 Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves Mariam T Nawas, Gunjan L. Shah, Darren R. Feldman, Josel D. Ruiz, Elizabeth V. Robilotti, Anoshe A. Aslam, et al. (+22)
11 [GO] 2021―Jan―31 Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19 Spyridoula Vasileiou, Manik Kuvalekar, Aster Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, et al. (+7)
12 [GO] 2021―Jan―31 Clinical Presentation and Outcomes of COVID-19 Following Hematopoietic Cell Transplantation Jose F. Camargo, Maria A Mendoza, Rick Y Lin, Ilona Moroz, Anthony D. Anderson, Michele I Morris, et al. (+9)
13 [GO] 2021―Jan―31 COVID-19 in Hematopoietic Cell Transplant Recipients: A CIBMTR Study Akshay Sharma, Neel S. Bhatt, Andrew St. Martin, Muhammad Bilal Abid, Jenni Bloomquist, Roy F. Chemaly, et al. (+10)
14 [GO] 2021―Jan―31 CD34+ Selection and T-Cell Add-Back Ensures Engraftment and Overall Safety with Unrelated Donor Cryopreserved Stem Cell Grafts during the COVID-19 Pandemic Randy M Windreich, Heather Stanczak, Jessie L Barnum, Paul Szabolcs
15 [GO] 2021―Jan―31 Non-Utilization of Cryopreserved Stem Cell Products from Unrelated Donors during the COVID-19 Pandemic Deborah Buk, Thilo Mengling, Susanne Seitz, Alexander Platz, Alexander H. Schmidt
16 [GO] 2021―Jan―31 Impact of COVID-19 Pandemic on Hematopoietic Stem Cell Transplantation (HSCT) and Immune Effector Cell (IEC) Therapies: A Large US Cancer Center Experience Katie Maurer, Anna Saucier, Haesook Kim, Utkarsh H. Acharya, Clifton Mo, Julie Porter, et al. (+7)
17 [GO] 2021―Jan―31 Unrelated Donor Usage for Allogeneic HCT in Canada during the First 6 Months of the COVID-19 Pandemic: A Canadian Blood Services Stem Cell Registry Analysis David Allan, Meagan Green, Gail Morris, Jason T. Weiss, Nicholas Dibdin, Dena Mercer, Heidi Elmoazzen
18 [GO] 2021―Jan―31 Remdesivir Therapy for COVID-19 Pneumonia in a Pediatric Bone Marrow Transplant Patient Viney Hardit, Prasanth Narahari, Julio Barredo, Asha Pillai, Warren Alperstein, Sonia Boodram, Edward Ziga
19 [GO] 2021―Jan―31 Coronavirus-Specific T-Cells Can be Rapidly Expanded from Convalescent Donors for Potential Clinical Use Michael D. Keller, Katherine M. Harris, Susan Conway, Jessica Durkee-Shock, Mariah Jensen-Wachspress, Vaishnavi V Kankate, et al. (+25)
20 [GO] 2021―Jan―31 Immunophenotypic Profiling of Immune Cells in Patients with and without Hematologic Malignancies Affected By Sars-COV-2 Infection Gabriela Sanchez-Petitto, Forat Lutfi, Jonathan Siglin, Ali Bukhari, David Gottlieb, Aaron P. Rapoport, et al. (+2)
21 [GO] 2021―Jan―31 Sars-Cov-2 Infections in CAR T Cell Recipients Kevin O. McNerney, Caroline Diorio, Chakkapong Burudpakdee, Julie Chase, Jessica Lee, Sarah E. Henrickson, et al. (+9)
22 [GO] 2021―Jan―31 Learning at Home: Implementing an Adaptable Tele-Education Model for Autologous Transplant Caregivers amidst a Global Pandemic Samuel K. Wickham, Justin Cook Solle, Amy Emmert, Lauren Daniels, Anna Pullo, Sara Close
23 [GO] 2021―Jan―31 The Incidence of Viral Upper Respiratory Tract Infection in Allogeneic Bone Marrow Transplant Recipients during the COVID Pandemic Guneet Kaleka, Pryce Gaynor, Caspian Oliai, Wanxing Chai-Ho, Gary J. Schiller
24 [GO] 2021―Jan―31 Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care Perla Rocío Colunga-Pedraza, Julia E. Colunga-Pedraza, Andrés Gómez De León, Mónica Bustillos-Muñoz, Karen Lorena Osorno-Rodríguez, José Ángel Hawing, et al. (+9)
25 [GO] 2021―Jan―31 Adapting Virtual Care in a Global Pandemic: Telemedicine As a Useful Alternative in Clinical Practice in the Stem Cell Transplant Program at Dana-Farber Cancer Institute Justin Cook Solle, Samuel K. Wickham, Jill Tierney, Julie Porter, Vincent T. Ho, Robert Soiffer, Corey Cutler
26 [GO] 2021―Jan―31 Resiliency during a COVID 19 Pandemic: The Quality Manager Perspective Therese Dodd, James Wade Atkins, Jennifer A. Christian, Karen Collum, Heather J. Conway, Orpheulia Davis, et al. (+7)
27 [GO] 2021―Jan―14 The Intersection of Photopheresis and COVID-19 Vaccination Garrett S. Booth, Bipin N. Savani
28 [GO] 2020―Dec―31 Letter to the Editor Regarding “Pre-HCT Lung Computed Tomography as an Alternative to PFT During the COVID-19 Pandemic Amin Pastaki Khoshbin, Rasoul Aliannejad
29 [GO] 2020―Dec―31 Meeting the demand for unrelated donors in the midst of the COVID-19 pandemic: Rapid adaptations by The National Marrow Donor Program and its network partners ensured a safe supply of donor products Jeffery J. Auletta, Jen L. Novakovich, Gretta L. Stritesky, Jeni Newman, Sade T. Fridy-Chesser, Karl Hailperin, Steven M. Devine
30 [GO] 2020―Dec―31 Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation Nina Worel, Bronwen E. Shaw, Mahmoud Aljurf, Mickey Koh, Adriana Seber, Daniel Weisdorf, et al. (+10)


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.011 sec